nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel minicircle vector based system for inhibting the replication and gene expression of Enterovirus 71 and Coxsackievirus A16
|
Yang, Zhuo |
|
2012 |
96 |
2 |
p. 234-244 11 p. |
artikel |
2 |
Are novel combination therapies needed for chronic hepatitis B?
|
Zoulim, Fabien |
|
2012 |
96 |
2 |
p. 256-259 4 p. |
artikel |
3 |
A small molecule screen in yeast identifies inhibitors targeting protein–protein interactions within the vaccinia virus replication complex
|
Flusin, Olivier |
|
2012 |
96 |
2 |
p. 187-195 9 p. |
artikel |
4 |
Comparison of rescue strategies in lamivudine-resistant patients with chronic hepatitis B
|
Zhao, Pan |
|
2012 |
96 |
2 |
p. 100-104 5 p. |
artikel |
5 |
Corrigendum to “Inhibition of rotavirus infection in cultured cells by N-acetyl-cysteine, PPARγ agonists and NSAIDs” [Antiviral Research 96(1) (2012) 1–12]
|
Guerrero, Carlos A. |
|
2012 |
96 |
2 |
p. 269- 1 p. |
artikel |
6 |
Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors
|
Zhao, Xin |
|
2012 |
96 |
2 |
p. 91-99 9 p. |
artikel |
7 |
Efficacy of an antiviral compound to inhibit replication of multiple pestivirus species
|
Newcomer, Benjamin W. |
|
2012 |
96 |
2 |
p. 127-129 3 p. |
artikel |
8 |
Eight flavonoids and their potential as inhibitors of human cytomegalovirus replication
|
Cotin, Sébastien |
|
2012 |
96 |
2 |
p. 181-186 6 p. |
artikel |
9 |
Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents
|
Kim, Su-Mi |
|
2012 |
96 |
2 |
p. 213-220 8 p. |
artikel |
10 |
Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation
|
Ndjomou, Jean |
|
2012 |
96 |
2 |
p. 245-255 11 p. |
artikel |
11 |
Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients
|
Yan, Chun-Hui |
|
2012 |
96 |
2 |
p. 108-114 7 p. |
artikel |
12 |
Inside Back Cover: Notes to Authors
|
|
|
2012 |
96 |
2 |
p. IBC- 1 p. |
artikel |
13 |
Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin
|
Zhao, Lan-Juan |
|
2012 |
96 |
2 |
p. 260-268 9 p. |
artikel |
14 |
In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients
|
Grammen, Carolien |
|
2012 |
96 |
2 |
p. 226-233 8 p. |
artikel |
15 |
Oseltamivir–zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections
|
Escuret, Vanessa |
|
2012 |
96 |
2 |
p. 130-137 8 p. |
artikel |
16 |
Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections – Potential as a dual functional microbicide
|
Qiu, Min |
|
2012 |
96 |
2 |
p. 138-147 10 p. |
artikel |
17 |
Prelim II: Editorial Board
|
|
|
2012 |
96 |
2 |
p. ii- 1 p. |
artikel |
18 |
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt’s lymphoma cells by affecting multiple molecular targets
|
De Leo, Alessandra |
|
2012 |
96 |
2 |
p. 196-202 7 p. |
artikel |
19 |
Safety and efficacy of tenofovir/IQP-0528 combination gels – A dual compartment microbicide for HIV-1 prevention
|
Dezzutti, Charlene S. |
|
2012 |
96 |
2 |
p. 221-225 5 p. |
artikel |
20 |
Selection pressure on the hepatitis B virus pre-S/S and P open reading frames in Tongan subjects with a chronic hepatitis B virus infection
|
Abbott, William G.H. |
|
2012 |
96 |
2 |
p. 148-157 10 p. |
artikel |
21 |
Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance
|
Sauerbrei, Andreas |
|
2012 |
96 |
2 |
p. 105-107 3 p. |
artikel |
22 |
Structural biology of dengue virus enzymes: Towards rational design of therapeutics
|
Noble, Christian G. |
|
2012 |
96 |
2 |
p. 115-126 12 p. |
artikel |
23 |
The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides
|
Magee, Wendy C. |
|
2012 |
96 |
2 |
p. 169-180 12 p. |
artikel |
24 |
The maximum potential market for dengue drugs V 1.0
|
Dow, Geoffrey |
|
2012 |
96 |
2 |
p. 203-212 10 p. |
artikel |
25 |
WFDC1/ps20: A host factor that influences the neutrophil response to murine hepatitis virus (MHV) 1 infection
|
Rogers, Erin |
|
2012 |
96 |
2 |
p. 158-168 11 p. |
artikel |